A case of severe, refractory diabetic gastroparesis managed by prolonged use of aprepitant

Nature Reviews Endocrinology

Volumn 5, Issue 5, 2009, Pages 286-288

  Chong, Kiang ^a   Dhatariya, Ketan ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APREPITANT; BOTULINUM TOXIN; CYCLIZINE; DOMPERIDONE; ERYTHROMYCIN; HALOPERIDOL; HEMOGLOBIN A1C; INSULIN; METOCLOPRAMIDE; OCTREOTIDE; ONDANSETRON; ANTIEMETIC AGENT; MORPHOLINE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIABETIC KETOACIDOSIS; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; JEJUNOSTOMY TUBE; LONG TERM CARE; LOW DRUG DOSE; PRIORITY JOURNAL; STOMACH PARESIS; VOMITING; TREATMENT OUTCOME;

ADULT; ANTIEMETICS; DIABETES MELLITUS, TYPE 1; FEMALE; GASTROPARESIS; HUMANS; MORPHOLINES; TREATMENT OUTCOME;

EID: 67651174568     PISSN: 17595029     EISSN: 17595037     Source Type: Journal    
DOI: 10.1038/nrendo.2009.50     Document Type: Article

References (17)

1. Camilleri, M. Clinical practice. diabetic gastroparesis. N. Engl. J. Med. 356, 820-829 (2007).
2. Soykan, I., Sivri, B., Sarosiek, I., Kiernan, B. & Mccallum, R. W. demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig. Dis. Sci. 43, 2398-2404 (1998).
3. Kockar, M. C., Kayahan, I. K. & Baybek, N. diabetic gastroparesis in association with autonomic neuropathy and microvasculopathy. Acta Med. Okayama 56, 237-243 (2002).
4. Jones, K. L., et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 24, 1264-1269 (2001).
5. Lacy, B. E., Crowell, M. D., Schettler-duncan, S., Mathis, C. & Pasricha, P. J. the treatment of diabetic gastroparesis with botulinum toxin injection of the pylorus. Diabetes Care 27, 2341-2347 (2004).
6. edmunds, M. C., Chen, J. D., Soykan, I., Lin, Z. & Mccallum, R. W. effect of octreotide on gastric and small bowel motility in patients with gastroparesis. Aliment. Pharmacol. Ther. 12, 167-174 (1998).
7. american society of clinical Oncology, et al. american society of clinical Oncology guideline for antiemetics in oncology: update 2006. J. Clin. Oncol. 24, 2932-2947 (2006).
8. National comprehensive cancer Network. NccN clinical practice guidelines in oncology, v.2.2009: antiemesis http://www.nccn.org/professionals/physician- gls/pdf/antiemesis.pdf (2009).
9. Madsen, J. L. & Fuglsang, s. a randomized, placebo-controlled, crossover, double-blind trial of the NK1 receptor antagonist aprepitant on gastrointestinal motor function in healthy humans. Aliment. Pharmacol. Ther. 27, 609-615 (2008).
10. Mccallum, R. W., Cynshi, O. & Investigative team. clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis-a randomized, multicentre, placebo-controlled study. Aliment. Pharmacol. Ther. 26, 1121-1130 (2007).
11. Chawla, S. P., et al. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Cancer 97, 2290-2300 (2008).
12. Navari, R. M., et al. Reduction of cisplatininduced emesis by a selective neurokinin-1-receptor antagonist. L-754, 030 antiemetic trials Group. N. Engl. J. Med. 340, 190-195 (1999).
13. Keller, M., et al. Lack of efficacy of the substance P (neurokinin 1 receptor) antagonist aprepitant in the treatment of major depressive disorder. Biol. Psychiatry 59, 216-223 (2006).
14. Abell, T., et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology 125, 421-428 (2003).
15. Lin, Z., Mcelhinney, C., Sarosiek, I., Forster, J. & Mccallum, R. Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalizations. Dig. Dis. Sci. 50, 1328-1334 (2005).
16. Lin, Z., Sarosiek, I., Forster, J. & Mccallum, R. W. symptom responses, longterm outcomes and adverse events beyond 3 years of high-frequency gastric electrical stimulation for gastroparesis. Neurogastroenterol. Motil. 18, 18-27 (2007).
17. Parkman, H. P., et al. American Gastroenterological association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology 127, 1592-1622 (2004).